Ibiden Co.,Ltd.
IBIDF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $545 | $969 | $723 | $1,007 |
| - Cash | $391 | $444 | $302 | $186 |
| + Debt | $343 | $344 | $270 | $175 |
| Enterprise Value | $498 | $869 | $690 | $997 |
| Revenue | $369 | $371 | $418 | $401 |
| % Growth | -0.3% | -11.3% | 4.1% | – |
| Gross Profit | $113 | $102 | $128 | $120 |
| % Margin | 30.7% | 27.7% | 30.5% | 29.9% |
| EBITDA | $107 | $94 | $127 | $112 |
| % Margin | 28.9% | 25.4% | 30.5% | 28% |
| Net Income | $34 | $31 | $52 | $41 |
| % Margin | 9.1% | 8.5% | 12.5% | 10.3% |
| EPS Diluted | 226.19 | 224.86 | 373.73 | 295.34 |
| % Growth | 0.6% | -39.8% | 26.5% | – |
| Operating Cash Flow | $119 | $145 | $126 | $108 |
| Capital Expenditures | -$199 | -$86 | -$104 | -$67 |
| Free Cash Flow | -$80 | $59 | $22 | $41 |